Retraction note: Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria

doi:10.12998/wjcc.v12.i19.4029

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 19

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1057)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

914

Sum=933

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=94

Jul 6, 2024 (publication date) through Nov 9, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retraction Note

World J Clin Cases. Jul 6, 2024; 12(19): 4029-4030
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.4029

Retraction note: Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria

Jia-Ping Yan, Jin-Lei Wang

Jia-Ping Yan, Jin-Lei Wang, Baishideng Publishing Group Inc, Pleasanton, CA 94566, United States

Author contributions: Yan JP and Wang JL wrote and proofread this retraction note.

Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Jin-Lei Wang, MSc, Director, Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, United States. j.l.wang@wjgnet.com

Received: June 28, 2024
Revised: June 28, 2024
Accepted: June 28, 2024
Published online: July 6, 2024
Processing time: 1 Days and 10 Hours

Core Tip

Core Tip: A reader found that an article published in World Journal of Clinical Cases(WJCC) is fraught with drawbacks. After careful evaluation, the WJCC Editorial Office decided to retract this article.